Overview / Abstract: |
STATEMENT OF NEED Tumor lysis syndrome (TLS) is an oncological emergency that occurs when massive tumor lysis causes the rapid release of intracellular components into the bloodstream. Electrolyte imbalances characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia may be severe enough to cause acute renal failure, cardiac arrhythmias, seizures, and even death. Current advances in cancer therapies can increase the incidence of TLS; therefore, identification of patients at risk for TLS and prophylactic measures to prevent TLS are critically important to preventing morbidity and mortality. This manuscript reviews the pathophysiology of TLS, the identification of patients at risk of TLS and the appropriate prophylactic treatment, the signs and symptoms of TLS, and supportive care measures to optimize outcomes when TLS does occur. TARGET AUDIENCE Oncology nurses, nurse practitioners, clinical nurse specialists, and other health care professionals involved in the treatment of various tumor types LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: Distinguish the risk factors, signs and symptoms of clinical and laboratory tumor lysis syndrome To claim your NCPD certificate for this activity, please complete the following steps: Take the pretest For virtual (asynchronous, archived live, home study; synchronous webinars) CME/NCPD/CE activities, include access to system requirements: The Internet browser(s) supported and minimum versions of each required by the learner to complete the online activity. |
Expiration |
Oct 16, 2024 |
Discipline(s) |
Nurse Practitioner , Nursing CNE |
Format |
Online |
Credits / Hours |
1.25 Contact Hours |
Accreditation |
ANCC, ACCME, ACPE |
Keywords / Search Terms |
i3 Health nurses, CE, oncology, oncology nursing, tumor, tumor lysis syndrome, cancer care, supportive care, hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia Free CE CME |